February 2013

We have dedicated a large portion of this blog to covering “conflicts of interest” or COIs, and the various claims being made…

Earlier this month, the Food and Drug Administration (FDA) released a notice for public comment in the Federal Register regarding…

Over the last several years, we have written extensively about the ongoing government prosecution of pharmaceutical and medical…

The Office of the Inspector General (OIG) for the Department of Health and Human Services (HHS) released a report, which asserts…

Below is a list in alphabetic order of the major pharmaceutical and medical device manufacturer corporate integrity agreements…

This week, the Centers for Medicare & Medicaid Services (CMS) launched a website which will host the National Physician…

Prescription medicines help people avoid the disability and death caused by disease, and help lower overall treatment costs. In…

As we noted earlier this month, the Centers for Medicare & Medicaid Services (CMS) released the final regulations to implement…

Adding to the long list of pharmaceutical settlements involving off-label promotion, Amgen Inc., the world’s largest biotechnology…

Each year, the Alliance for Continuing Education in the Health Professions (ACEHP) holds its annual meeting, bringing together…